Wellstone Center News and Events

2027 Wellstone Conference Save the Date
2025 Wellstone Conference Group Photo
2025 Wellstone Conference Group Photo
2026 Wellstone Conference Group Photo
Patients, families, and staff gather for a group photo during the 2026 Dystroglycanopathies Patient & Family Conference

Latest News

Dr. Kevin Campbell is the recipient of the 2026 August M. Watanabe Prize in Translational Research

Kevin Campbell, PhD, is the 2026 winner of the August M. Watanabe Prize in Translational Research and was honored at the Indiana Clinical and Translational Sciences Institute (CTSI) Annual Meeting in September.

Campbell is well known for his work elucidating cellular and molecular mechanisms underlying various forms of muscular dystrophy. Providing a scientific foundation for novel treatment strategies, his research has led to seminal discoveries advancing the understanding of skeletal muscle biology and offering critical insight into the pathogenesis of muscular dystrophy.

Dr. Kevin Campbell Earns 2025 Horwitz Prize for Muscular Dystrophy Discoveries

Campbell shares the prize, which is awarded annually for groundbreaking work in medical science, with fellow researchers Louis Kunkel and Eric Olson for discoveries that revealed the biological causes of Duchenne muscular dystrophy and provide the foundation for breakthrough treatments for this and related muscular diseases.

The Horwitz Prize recognizes Campbell’s contributions to understanding Duchenne muscular dystrophy (DMD), a severe genetic disorder affecting approximately 1 in every 3,500 to 5,000 male births worldwide. The disease is caused by mutations in the dystrophin gene, which is essential for the stability of muscle fibers and the heart. Without intervention, DMD begins to impair mobility in adolescence, and can progress rapidly, causing early death from heart and lung failure.

Campbell's pioneering work revealed that dystrophin proteins form structural scaffolds with glycoproteins — proteins with sugar molecules attached to them — inside the cell and disrupting these scaffolds destabilizes muscle fibers. This work provided essential insights into the biological causes of several forms of muscular dystrophy, which has profound implications for the diagnosis and treatment of these diseases.

The collective work of Campbell, Kunkel, and Olson honored by the Horwitz Prize has advanced scientific understanding of muscular dystrophies and brought real hope of potential therapies for the thousands of families affected by these devastating diseases.

Dr. Kevin Campbell Receives 2025 LGMD Scientific Excellence Award

Dr. Kevin Campbell was honored with the LGMD Scientific Excellence Award at the 2025 International Limb Girdle Muscular Dystrophy Conference in Orlando, Florida. This prestigious recognition celebrates his unwavering dedication, impactful research, and continued leadership in advancing the field. His contributions have made a lasting difference within the LGMD community and continue to inspire scientists, clinicians, and advocates alike.

Campbell Keynote Lecture at the American Society of Gene and Cell Therapy meeting (May 2024)

https://www.cgtlive.com/view/campbell-challenges-gene-therapy-approaches-advanced-muscular-dystrophy

bioRxiv Latest Findings

bioRxiv is free online repository for scientific pre-prints which have not yet been peer-viewed. Posting research findings as pre-prints makes the information available to the muscular dystrophy community as soon as possible. Here are the latest research findings from the Campbell Laboratory:

New Publications

The Iowa Wellstone MDSRC is excited to share the latest research from Dr. Kevin Campbell's laboratory: 

Xylose phosphatase activity of dystroglycan self-regulates its receptor function, published in Science.

N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy, published in eLife.

Awards and Lectures

  • Dr. Steven Moore, Co-Director of the Iowa Wellstone MDSRC, was invited to give the 2022 Saul R. Korey Lectureship at the American Association of Neuropathologists (AANP) Annual Meeting. The Korey Lectureship was established in 1989 by Dr. Robert D. Terry, a pioneer in Alzheimer’s disease research, to honor Dr. Korey, the founder and first chair of the Department of Neurology at Albert Einstein College of Medicine. As described by Dr. Terry, the Korey Lectureship recognizes someone who has "been an active member of the Association...a working Neuropathologist...responsible for diagnostic work as well as teaching and research.” Or, as the AANP states, someone who has “done it all and done it well.” Dr. Moore's lecture was titled "Adventures in Muscular Dystrophy: the DGC, LAMA2, and Other Sticky Relationships." Dr. Moore was also awarded the AANP 2022 Award for Meritorious Contributions. Congratulations Dr. Moore!

  • Dr. Katherine Mathews, who leads the clinical research project at the Iowa MDSRC, received the second annual "Pioneer for LGMD2i" award from the CureLGMD2i committee. The award was announced at the CureLGMD2i's 11th annual casino event, a fundraising event held with a virtual component on October 2, 2021. Lacey Woods, the first annual "Pioneer for LGMD2i" award recipient, created a video to present the award to Dr. Mathews, who also accepted the honor through a video shown at the event. Congratulations Dr. Mathews!

Recent Publications

Basic Science Research

Basic science research in Project 1 investigates the cellular and molecular mechanisms that underlie the dystroglycanopathies to provide a scientific foundation for the development of diagnostic and therapeutic strategies, as well as approaches to monitoring the efficacy of potential therapies. 

Clinical Research

Data collected from Wellstone study patients in Project 2 is analyzed and published in order to inform researchers and clinicians about disease progression and improve patient care.

Diagnostics Research

Diagnostics research draws on the broad spectrum of skeletal muscle biopsies available in Core B to investigate and develop novel diagnostic testing procedures for muscular dystrophy and to expand the toolbox of evaluation techniques for muscle biopsies and cell cultures from dystroglycanopathy patients.

More Publications from Wellstone Center Investigators

Recent Invited Lectures and Talks by Wellstone Center Investigators

Dr. Kevin Campbell

2025 

  • 8th International Glycosylation Workshop, Charlotte, North Carolina
  • International LGMD Conference, Orlando, Florida
  • International Conference on Muscle Wasting, Ascona, Switzerland
  • Muscular Dystrophy Coordinating Committee Meeting (NIH), Bethesda, Maryland (virtual)

2024 

  • Association of University Cardiologists Meeting, Charleston, South Carolina
  • American Society of Gene & Cell Therapy Annual Meeting, Baltimore, Maryland
  • 65th Annual Meeting of Japanese Society of Neurology, Tokyo, Japan
  • Nationwide Children’s Hospital/Ohio State University Myology Course, Columbus, Ohio
  • Karl Meyer Award Lecture, Society of Glycobiology Annual Meeting, Amelia Island, Florida

2023   

  • Glycobiology Gordon Research Conference, Ventura, California
  • Baylor College of Medicine Child Neurology Grand Rounds, Houston, Texas
  • 7th International Workshop for Glycosylation Defects in Muscular Dystrophy, Charlotte, North Carolina
  • Wash U Compass Fireside Chat, St. Louis, Missouri, Virtual
  • Presidents Lecture Series at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California
  • Augusta University Lombard Kelly Lecture, Augusta, Georgia
  • Society of Glycobiology Annual Meeting, Big Island, Hawaii
  • University of Iowa Neurology Grand Rounds, Iowa City, Iowa

2022   

  • The 3rd ENMC Workshop on Dystroglycan and the Dystroglycanopathies, Hoofddorp, The Netherlands
  • Scripps Molecular Medicine Seminar, San Diego, California
  • International Conference on Muscle Wasting, Ascona, Switzerland
  • University of Iowa Neuromuscular-Neurogenetics Symposium, Iowa City, Iowa
  • University of Rochester Inaugural Paul LaCelle Lecture, Rochester, New York

2021   

  • Regeneron Seminar Series, Tarrytown, New York, Virtual
  • Albert Einstein College of Medicine, Cell Biology Outside Speaker Seminar Series, Bronx, New York, Virtual
  • San Diego Glycobiology Symposium, San Diego, California, Virtual
  • ASBMB Herbert Tabor Award Lecture, San Diego, California, Virtual (Voted one of the "Most Favorited" sessions and presentations, Experimental Biology 2021 conference)
  • Joint Glycobiology Meeting, Heidelberg, Germany, Virtual
  • Tamio Yamakawa Award Lecture, Osaka, Japan, Virtual

Dr. Katherine Mathews

2023

  • Treat NMD Masterclass, Virtual
  • CureCMD Roundtable Presentation and Discussion, Virtual
  • MDA Clinical and Scientific Conference, Dallas, Texas
  • Parent Project Muscular Dystrophy Cardiac Workshop, New Orleans, Louisiana
  • 7th International Workshop for Glycosylation Defects in Muscular Dystrophy, Charlotte, North Carolina
  • Treat NMD Conference, London, United Kingdom
  • Ottawa Neuromuscular Conference, Ottawa Canada
  • Neuromuscular Study Group Annual Meeting, Orlando, Florida
  • Solve FSHD Summit

2022

  • FSHD Society, Virtual Webinar
  • Patient Focused Drug Development Meeting with the FDA, organized by Coalition to Cure Calpain 3, Kurt + Peter Foundation, LGMD2D Foundation, The SPEAK Foundation, Cure LGMD2i, and the McColl-Lockwood Laboratory for Muscular Dystrophy Research

2021

  • MDA Engage Pediatric Neuromuscular Seminar for Patients and Families, Virtual
  • FSHD Masterclass, Virtual

Dr. Steven Moore

2023

  • MDA Clinical and Scientific Conference, Dallas, Texas

2021

  • 2021 Academy of Clinical Laboratory Physicians and Scientists (ACLPS) Meeting, Virtual